Baxter International Inc. (BTL.F)
| Previous close | 31.05 |
| Open | 30.80 |
| Bid | 32.09 x 13000 |
| Ask | 32.31 x 12700 |
| Day's range | 30.80 - 30.80 |
| 52-week range | 29.45 - 44.20 |
| Volume | |
| Avg. volume | 156 |
| Market cap | 16.456B |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.07 |
| Earnings date | 25 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | 1.08 (3.51%) |
| Ex-dividend date | 31 May 2024 |
| 1y target est | 94.13 |
ReutersCarlyle in talks to buy Baxter's kidney care unit, source says
Shares of the Deerfield, Illinois-based firm rose more than 4%. Medical device maker Baxter said in March it had been in discussions with select private equity investors to explore a potential sale of the kidney care unit more than a year after it announced plans to separate the unit amid supply-chain challenges and weak demand for dialysis operations. Baxter declined to comment while Carlyle did not immediately respond to a Reuters request for comment.
ZacksReasons to Retain Baxter International (BAX) in Your Portfolio Now
Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales.
Insider MonkeyDid Baxter International Inc. (BAX) Beat the Market in Q1?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where Baxter International Inc. (NYSE:BAX) stands against the other healthcare stocks under $50. If interested, you can also read our recent article on the 10 Best Healthcare Stocks To […]
